AI meets healthcare in upcoming FDA project!
FDA and OpenAI Chat about AI in Drug Evaluations under the CDERGPT Project
Last updated:
In an exciting development, FDA is reportedly engaging in discussions with OpenAI about employing AI for drug evaluations. This initiative, dubbed the CDERGPT project, aims to streamline the drug approval process, potentially making it more efficient and accurate. While still in the early stages, this collaboration could herald a new era in how medications are assessed and approved, blending healthcare and AI innovation in an unprecedented fashion.
Introduction to CDERGPT Project
Learn to use AI like a Pro
Get the latest AI workflows to boost your productivity and business performance, delivered weekly by expert consultants. Enjoy step-by-step guides, weekly Q&A sessions, and full access to our AI workflow archive.














OpenAI's Collaboration with FDA
Learn to use AI like a Pro
Get the latest AI workflows to boost your productivity and business performance, delivered weekly by expert consultants. Enjoy step-by-step guides, weekly Q&A sessions, and full access to our AI workflow archive.














AI in Drug Evaluations
Learn to use AI like a Pro
Get the latest AI workflows to boost your productivity and business performance, delivered weekly by expert consultants. Enjoy step-by-step guides, weekly Q&A sessions, and full access to our AI workflow archive.














Expert Opinions on CDERGPT
Public Reactions and Insights
Learn to use AI like a Pro
Get the latest AI workflows to boost your productivity and business performance, delivered weekly by expert consultants. Enjoy step-by-step guides, weekly Q&A sessions, and full access to our AI workflow archive.













